Skip to main content
STARSOURCE MULTITRADE LIMITED logo

STARSOURCE MULTITRADE LIMITED — Investor Relations & Filings

Ticker · 506365 ISIN · INE320M01019 BSE.NS Wholesale and retail trade
Filings indexed 319 across all filing types
Latest filing 2025-04-16 Regulatory Filings
Country IN India
Listing BSE.NS 506365

About STARSOURCE MULTITRADE LIMITED

https://starsourcemultitrade.com/

STARSOURCE MULTITRADE LIMITED is a commercial entity engaged in the wholesale distribution and trading of a broad range of products. The organization primarily focuses on the procurement, supply, and logistics of textiles, fabrics, and related materials. Its core operations involve managing complex supply chains to connect manufacturers with diverse market segments. The company prioritizes the sourcing of high-quality goods and maintains a robust distribution network to ensure efficient delivery and market responsiveness. By focusing on bulk trading and strategic sourcing, the firm serves as a key intermediary in the movement of materials across various commercial channels.

Recent filings

Filing Released Lang Actions
OUTCOME OF THE BOARD MEETING HELD ON WEDNESDAY, APRIL 16, 2025
Regulatory Filings
2025-04-16 English
Format of Initial Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details ....
Regulatory Filings Classification · 95% confidence The document is a letter addressed to the Bombay Stock Exchange regarding the non-applicability of a specific SEBI circular related to fund raising by issuance of debt securities by large entities. It confirms that the company is not classified as a Large Corporate as per the SEBI framework as of March 31, 2025. The document is a regulatory disclosure or compliance statement rather than a financial report, audit, or management discussion. It does not contain financial statements or detailed financial data, nor does it announce a meeting or voting results. It is a regulatory filing informing the exchange of a compliance status related to a regulatory circular. Therefore, it fits best under Regulatory Filings (RNS). The document length is short and it is a formal disclosure to a regulatory body, consistent with RNS filings.
2025-04-16 English
Format of Initial Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details ....
Regulatory Filings Classification · 95% confidence The document is a letter addressed to the Bombay Stock Exchange regarding the non-applicability of a specific SEBI circular related to fund raising by issuance of debt securities by large entities. It confirms that the company is not classified as a Large Corporate as per the SEBI framework as of March 31, 2025. The document is short (1556 characters) and serves as a regulatory disclosure rather than a financial report or detailed filing. It does not contain financial statements, audit information, or management discussion. It is an official regulatory announcement related to compliance with SEBI regulations, fitting the description of a Regulatory Filing (RNS).
2025-04-15 English
Declaration of Non-Applicability of Regulation 23(9) of SEBI (LODR) Regulation, 2015
Regulatory Filings
2025-04-15 English
Chemo Pharma Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 16/04/2025 ,inter alia, to consider and approve Appointment of Directors ....
Regulatory Filings
2025-04-08 English
Compliance Certificate under Reg. 74(5) of SEBI (DP) Regulation 2018 for the Quarter Ended March 31, 2025
Regulatory Filings Classification · 100% confidence The document is a certificate submitted under Regulation 74(5) of the Securities and Exchange Board of India (Depositories and Participants) Regulations, 2018, for the quarter ended March 31, 2025. It is a confirmation certificate issued by the company's Registrar and Share Transfer Agent confirming compliance with dematerialisation of shares and related processes. The document contains no financial statements or management discussion but is a regulatory compliance certificate. It is not an annual or interim report, earnings release, or any other financial report. It is a regulatory filing related to securities regulations and compliance.
2025-04-02 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.